The Anti-Longevity PlaybookGet the Playbook
Evidence Review
Rapamycin
Verdict
WatchingEvidence Tier
B
Moderate evidence
Human Studies
Yes — limited for longevity
Typical Cost
$80-200/mo
Rapamycin is arguably the most interesting longevity drug in preclinical research. It extends lifespan in mice more consistently than any other compound tested. However, human longevity data does not yet exist. The drug has FDA approval for transplant immunosuppression, and off-label longevity use carries real risks including immunosuppression and metabolic side effects.
The full evidence review — including why the most promising longevity drug in mouse research isn't ready for your medicine cabinet — is in Section 2 (Supplements & Compounds) of The Anti-Longevity Playbook.
Reviewed by Dr. Ramy Khalil, MD · Double Board-Certified Internal Medicine · Last updated March 2026
Should I take rapamycin for longevity?
Rapamycin extends lifespan in mice more consistently than any compound tested, but human longevity data doesn't exist yet. Off-label use carries real risks including immunosuppression.
Free Chapter
Want the full picture?
Start with a free chapter.
Read the first chapter of The Anti-Longevity Playbook free — including the intervention with stronger mortality data than Rapamycin.
More from Supplements & Compounds
Browse All Evidence Reviews
30+ longevity interventions reviewed by a physician against the primary literature.
ExerciseStatinsApoB TestingNMNNMN vs. NR — Which Is Better?ResveratrolRapamycinMetformin for LongevityBPC-157PeptidesCold Plunge / Cold ExposureSaunaSleepTestosterone Replacement TherapyGrowth HormoneContinuous Glucose MonitorFull-Body MRI ScreeningBiological Age TestsSemaglutideTirzepatideIntermittent FastingCaloric RestrictionBerberineOmega-3 Fatty AcidsVitamin DMagnesiumCoQ10SpermidineCreatineSocial ConnectionAlcohol